Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FIVNNASDAQ:KEQUNASDAQ:MSONNASDAQ:THMO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFIVNFive9$26.85+0.8%$26.54$21.04▼$49.90$2.05B1.21.70 million shs529,566 shsKEQUKewaunee Scientific$57.99+5.8%$36.60$30.33▼$71.33$165.87M0.5623,379 shs24,106 shsMSONMisonix$26.54$26.18$11.04▼$26.99$462.06M1.3660,302 shs2 shsTHMOThermoGenesis$0.00$0.00▼$0.60$1K1.175,900 shsN/AThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFIVNFive9+0.15%-2.60%-2.88%-3.96%-34.59%KEQUKewaunee Scientific+35.38%+51.17%+42.19%+36.49%+41.46%MSONMisonix0.00%0.00%0.00%0.00%0.00%THMOThermoGenesis0.00%0.00%0.00%-66.67%-99.95%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFIVNFive94.2603 of 5 stars4.43.00.00.03.52.51.9KEQUKewaunee Scientific1.7759 of 5 stars0.04.00.00.02.12.51.3MSONMisonixN/AN/AN/AN/AN/AN/AN/AN/ATHMOThermoGenesisN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFIVNFive9 2.73Moderate Buy$43.1560.70% UpsideKEQUKewaunee Scientific 0.00N/AN/AN/AMSONMisonix 0.00N/AN/AN/ATHMOThermoGenesis 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MSON, KEQU, THMO, and FIVN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/6/2025FIVNFive9KeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$35.006/5/2025FIVNFive9KeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOverweight$35.005/13/2025FIVNFive9Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$36.00 ➝ $36.005/5/2025FIVNFive9BarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$60.00 ➝ $33.005/2/2025FIVNFive9UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$55.00 ➝ $35.005/2/2025FIVNFive9Royal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$30.00 ➝ $35.005/2/2025FIVNFive9Evercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$55.00 ➝ $40.005/2/2025FIVNFive9Needham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$52.00 ➝ $40.005/2/2025FIVNFive9Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$36.00 ➝ $36.004/28/2025FIVNFive9Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$45.00 ➝ $28.00(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFIVNFive9$1.04B1.97$2.20 per share12.19$8.27 per share3.25KEQUKewaunee Scientific$240.47M0.69$1.82 per share31.78N/A∞MSONMisonix$74.02M6.24N/AN/A$7.77 per share3.42THMOThermoGenesis$9.61M0.00N/AN/A($0.99) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFIVNFive9-$12.80M-$0.09N/A35.802.54-0.48%6.06%1.79%8/6/2025 (Estimated)KEQUKewaunee Scientific$18.75M$5.9115.20∞N/A4.74%26.69%10.56%9/9/2025 (Estimated)MSONMisonix-$14.47MN/AN/A∞N/A-19.55%-10.36%-7.29%N/ATHMOThermoGenesis-$17.98M-$5.14N/AN/AN/AN/AN/AN/AN/ALatest MSON, KEQU, THMO, and FIVN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/25/2025Q4 2025KEQUKewaunee ScientificN/A$1.95N/A$1.63N/A$77.15 million5/1/2025Q1 2025FIVNFive9$0.48$0.62+$0.14$0.01$272.26 million$279.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFIVNFive9N/AN/AN/AN/AN/AKEQUKewaunee ScientificN/AN/AN/AN/AN/AMSONMisonixN/AN/AN/AN/AN/ATHMOThermoGenesisN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFIVNFive91.122.022.02KEQUKewaunee Scientific0.622.161.54MSONMisonix0.292.611.92THMOThermoGenesisN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFIVNFive996.64%KEQUKewaunee Scientific32.69%MSONMisonix40.52%THMOThermoGenesis5.78%Insider OwnershipCompanyInsider OwnershipFIVNFive91.60%KEQUKewaunee Scientific14.20%MSONMisonix31.69%THMOThermoGenesis78.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFIVNFive93,07376.27 million75.05 millionOptionableKEQUKewaunee Scientific1,0062.85 million2.45 millionNot OptionableMSONMisonix25417.41 million11.89 millionNot OptionableTHMOThermoGenesis407.95 million1.75 millionNot OptionableMSON, KEQU, THMO, and FIVN HeadlinesRecent News About These CompaniesThe Ice Water Hack: How Aqua Sculpt Boosts Thermogenesis for Fat LossMarch 10, 2025 | globenewswire.comIce Water Hack: How Aqua Sculpt Improves Thermogenesis for Weight LossFebruary 20, 2025 | globenewswire.comNorth American Morning Briefing: Stock Futures, -2-September 19, 2024 | morningstar.comMIs Thermogenesis Holdings Inc Stock (THMO) a Good Investment?August 8, 2024 | aaii.comAThermoGenesis Holdings (OTC:THMO) Stock Quotes, Forecast and News SummaryJuly 28, 2024 | benzinga.comThermoGenesis Holdings (OTC:THMO) Stock, Short Interest ReportJuly 28, 2024 | benzinga.comWhy Is ThermoGenesis (THMO) Stock Down 37% Today?June 12, 2024 | investorplace.comTHMO Stock Earnings: ThermoGenesis Holdings Misses EPS, Misses Revenue for Q1 2024May 17, 2024 | investorplace.comThermoGenesis Holdings, Inc. (NASDAQ:THMO) Is About To Turn The CornerFebruary 27, 2024 | finance.yahoo.comThermoGenesis Holdings, Inc.January 9, 2024 | thestreet.comThermoGenesis Holdings Stock (NASDAQ:THMO) Dividends: History, Yield and DatesDecember 16, 2023 | benzinga.comShareholders Will Probably Hold Off On Increasing ThermoGenesis Holdings, Inc.'s (NASDAQ:THMO) CEO Compensation For The Time BeingDecember 8, 2023 | finance.yahoo.comThermoGenesis Holdings Recent Insider ActivityNovember 21, 2023 | benzinga.comThermoGenesis Holdings, Inc.: ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 15, 2023 | finanznachrichten.deThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | finance.yahoo.comThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 13, 2023 | finance.yahoo.comThermoGenesis Q3 Earnings PreviewNovember 12, 2023 | msn.comHere's what Wall Street expects from ThermoGenesis's earnings reportNovember 12, 2023 | markets.businessinsider.comThermoGenesis Holdings Inc THMONovember 12, 2023 | morningstar.comMThermoGenesis Holdings Earnings PreviewNovember 10, 2023 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMSON, KEQU, THMO, and FIVN Company DescriptionsFive9 NASDAQ:FIVN$26.85 +0.20 (+0.75%) As of 11:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Five9, Inc., together with its subsidiaries, provides intelligent cloud software for contact centers in the United States, India, and internationally. It offers a virtual contact center cloud platform that delivers a suite of applications, which enables the breadth of contact center-related customer service, sales, and marketing functions. The company's platform comprises of including interactive virtual agent, agent assist, workflow automation, workforce engagement management, AI insights, and AI summaries that allows to manage and optimize customer interactions across voice, chat, email, web, social media, and mobile channels directly or through its application programming interfaces. It also matches each customer interaction with an agent resource and delivers customer data to the agent in real-time through integrations with adjacent enterprise applications, such as CRM software, to optimize the customer experience and enhance agent productivity. The company serves customers in various industries, such as banking and financial services, business process outsourcers, retail, healthcare, technology, and education. Five9, Inc. was incorporated in 2001 and is headquartered in San Ramon, California.Kewaunee Scientific NASDAQ:KEQU$57.99 +3.19 (+5.83%) As of 11:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.Misonix NASDAQ:MSONMisonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.ThermoGenesis NASDAQ:THMOThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Skyworks Stock Down 16% in 2025, Poised for AI Edge Surge Is IBM’s AI Transformation Powering a Sustained Rally? Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst Tesla: The Next Month Could Make or Break the Year Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
